These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1545139)

  • 1. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF.
    Nanney LB; Yates RA; King LE
    J Invest Dermatol; 1992 Mar; 98(3):296-301. PubMed ID: 1545139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.
    Nanney LB; Stoscheck CM; Magid M; King LE
    J Invest Dermatol; 1986 Mar; 86(3):260-5. PubMed ID: 3018088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased epidermal growth factor receptor in fsn/fsn mice.
    Nanney LB; Sundberg JP; King LE
    J Invest Dermatol; 1996 Jun; 106(6):1169-74. PubMed ID: 8752652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced expression of transforming growth factor-alpha and the epidermal growth factor receptor in neonatal skin explants.
    Valyi-Nagy I; Jensen PJ; Albelda SM; Rodeck U
    J Invest Dermatol; 1992 Sep; 99(3):350-6. PubMed ID: 1512472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ribosomal protein S6 kinase in psoriatic lesions and cultured human keratinocytes by epidermal growth factor receptor ligands.
    Choi JH; O'Connor TP; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1997 Jan; 108(1):98-102. PubMed ID: 8980296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis.
    Higashiyama M; Hashimoto K; Matsumoto K; Yoshikawa K
    J Dermatol Sci; 1994 Feb; 7(1):45-53. PubMed ID: 7514888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased high-affinity epidermal growth factor receptors in psoriatic epidermis.
    Urano Y; Ikeuchi T; Fujimoto A; Asano T; Arase S; Shigemi F; Takeda K
    Tokushima J Exp Med; 1989 Dec; 36(3-4):53-8. PubMed ID: 2636999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor.
    Krane JF; Gottlieb AB; Carter DM; Krueger JG
    J Exp Med; 1992 Apr; 175(4):1081-90. PubMed ID: 1313074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of EGF-R during epidermal wound healing.
    Stoscheck CM; Nanney LB; King LE
    J Invest Dermatol; 1992 Nov; 99(5):645-9. PubMed ID: 1431229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mRNA is not increased in psoriatic skin.
    Kobayashi H; Yasuda H; Matsue H; Ohkawara A; Ogiso Y; Kuzumaki N
    J Dermatol; 1990 Feb; 17(2):104-7. PubMed ID: 2329220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
    Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
    Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human psoriatic skin in organ culture: comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor.
    Varani J; Kang S; Stoll S; Elder JT
    Pathobiology; 1998; 66(6):253-9. PubMed ID: 9769471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro.
    Gottlieb AB; Khandke L; Krane JF; Staiano-Coico L; Ashinoff R; Krueger JG
    J Invest Dermatol; 1992 May; 98(5):680-5. PubMed ID: 1314863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
    Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
    Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of cytokines on psoriatic skin grafted on nude mice: involvement of the tumour necrosis factor (TNF) receptor.
    Gilhar A; David M; Kalish RS; Weisinger G
    Clin Exp Immunol; 1996 Oct; 106(1):134-42. PubMed ID: 8870711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.